These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23347099)

  • 1. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis.
    Perez-Campo FM; Costa G; Lie-a-Ling M; Kouskoff V; Lacaud G
    Immunology; 2013 Jun; 139(2):161-5. PubMed ID: 23347099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
    Perez-Campo FM; Borrow J; Kouskoff V; Lacaud G
    Blood; 2009 May; 113(20):4866-74. PubMed ID: 19264921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOZ is essential for maintenance of hematopoietic stem cells.
    Katsumoto T; Aikawa Y; Iwama A; Ueda S; Ichikawa H; Ochiya T; Kitabayashi I
    Genes Dev; 2006 May; 20(10):1321-30. PubMed ID: 16702405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
    Katsumoto T; Yoshida N; Kitabayashi I
    Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOZ fusion proteins in acute myeloid leukaemia.
    Troke PJ; Kindle KB; Collins HM; Heery DM
    Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.
    Yang XJ; Ullah M
    Oncogene; 2007 Aug; 26(37):5408-19. PubMed ID: 17694082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells.
    Sheikh BN; Yang Y; Schreuder J; Nilsson SK; Bilardi R; Carotta S; McRae HM; Metcalf D; Voss AK; Thomas T
    Blood; 2016 Nov; 128(19):2307-2318. PubMed ID: 27663673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOZ and BMI1 act synergistically to maintain hematopoietic stem cells.
    Sheikh BN; Metcalf D; Voss AK; Thomas T
    Exp Hematol; 2017 Mar; 47():83-97.e8. PubMed ID: 27773671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis.
    Yokoyama A
    FEBS J; 2022 Dec; 289(24):7987-8002. PubMed ID: 34482632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.
    Thomas T; Corcoran LM; Gugasyan R; Dixon MP; Brodnicki T; Nutt SL; Metcalf D; Voss AK
    Genes Dev; 2006 May; 20(9):1175-86. PubMed ID: 16651658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors.
    Su J; Wang X; Bai Y; Sun M; Yao Y; Duan Y
    Pharmacol Res; 2021 Dec; 174():105930. PubMed ID: 34626770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis.
    Ohta K; Ohigashi M; Naganawa A; Ikeda H; Sakai M; Nishikawa J; Imagawa M; Osada S; Nishihara T
    Biochem J; 2007 Mar; 402(3):559-66. PubMed ID: 17083329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
    Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
    Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
    Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
    Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesodermal expression of Moz is necessary for cardiac septum development.
    Vanyai HK; Thomas T; Voss AK
    Dev Biol; 2015 Jul; 403(1):22-9. PubMed ID: 25912687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells.
    Perez-Campo FM; Costa G; Lie-A-Ling M; Stifani S; Kouskoff V; Lacaud G
    Stem Cells; 2014 Jun; 32(6):1591-601. PubMed ID: 24307508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MOZ histone acetyltransferase in epigenetic signaling and disease.
    Carlson S; Glass KC
    J Cell Physiol; 2014 Nov; 229(11):1571-4. PubMed ID: 24633655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
    Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
    Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
    Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
    Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.
    Sheikh BN; Lee SC; El-Saafin F; Vanyai HK; Hu Y; Pang SH; Grabow S; Strasser A; Nutt SL; Alexander WS; Smyth GK; Voss AK; Thomas T
    Blood; 2015 Mar; 125(12):1910-21. PubMed ID: 25605372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.